Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 44,860 | 43,970 | 40,138 | 36,257 | 34,147 |
| Cost of Goods | 20,816 | 19,959 | 18,284 | 16,586 | 15,774 |
| Gross Profit | 24,044 | 24,011 | 21,854 | 19,671 | 18,373 |
| Operating Expenses | 23,924 | 22,622 | 21,202 | 19,715 | 18,583 |
| Operating Income | 936 | 2,348 | 936 | 542 | 564 |
| Interest Expense | 162 | 260 | 256 | 192 | 235 |
| Other Income | 582 | 11 | 22 | 21 | 17 |
| Pre-tax Income | 1,356 | 2,099 | 702 | 371 | 346 |
| Income Tax | 231 | 172 | 121 | 33 | 154 |
| Net Income Continuous | 1,125 | 1,927 | 581 | 338 | 192 |
| Net Income | $1,125 | $1,927 | $581 | $338 | $192 |
| EPS Basic Total Ops | 0.03 | 0.04 | 0.02 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.03 | 0.05 | 0.02 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.03 | 0.06 | 0.01 | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.03 | 0.05 | 0.01 | 0.01 | 0.00 |
| EBITDA(a) | $3,592 | $5,107 | $3,466 | $2,721 | $2,638 |